[ad_1]
According to Pfizer and BioNTech, their vaccine is “90% effective” against Covid-19, according to the ongoing large-scale Phase 3 trial, the last step before an application for approval.
Reporter / DPA
The general manager of the German company BioNTech, which has developed a vaccine against the new coronavirus with Pfizer, spoke on Sunday of a possible return to normal by next winter.
At the BBC, Professor Ugur Sahin considered it “absolutely essential” to have a high rate of vaccinations before the autumn of 2021.
“If everything continues to go well, we will start providing the vaccine later this year,” he said. “Our goal is to deliver more than 300 million doses of the vaccine by April next year, which would allow us to begin making an impact” against the virus, which has killed more than 1.3 million worldwide. .
“The biggest impact will happen until the summer. Summer will help us anyway as the infection rate will drop, ”he continued. “What is absolutely essential is that we have a significant vaccination rate before the fall / winter of next year.”
We could have a normal winter next year.
“I am confident it will happen” because many vaccine manufacturers have been asked to increase production, he said, adding, “We could have a normal winter next year.”
According to Pfizer and BioNTech, their vaccine is “90% effective” against Covid-19, according to the ongoing large-scale Phase 3 trial, the last step before an application for approval.
Several other vaccines are also in this phase of research, suggesting the horizon for a return to normal.
Source link
